02 September 2025 : Original article
New-Onset Diabetes After Liver Transplantation: An SRTR Database Study of Incidence and Risk Factors
Saxiao Tang AEF 1,2, Shengmin Mei BCD 1, Shichao ShenDOI: 10.12659/AOT.949062
Ann Transplant 2025; 30:e949062
Table 3 Estimated risk factors for NODAT occurrence according to univariable and multivariable logistic regression analyses.
| Univariable model | Multivariable model | |||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p | OR | 95% CI | P | |
| Recipient age (≤50 years) | 0.79 | 0.73–0.86 | <0.001 | 0.78 | 0.69–0.89 | <0.001 |
| Male recipients | 1.19 | 1.09–1.28 | <0.001 | 1.21 | 1.07–1.34 | 0.002 |
| Recipient BMI (≤25 kg/m) | 0.84 | 0.77–0.91 | <0.001 | 0.84 | 0.75–0.94 | 0.003 |
| MELD | 1.00 | 0.99–1.01 | 0.446 | 1.01 | 0.99–1.02 | 0.076 |
| Pre-transplant medical condition (in hospital) | 1.00 | 0.93–1.09 | 0.920 | 0.98 | 0.84–1.14 | 0.795 |
| HLA mismatch ≥3 | 1.05 | 0.97–1.14 | 0.226 | 1.05 | 0.94–1.17 | 0.424 |
| CMV infection | 1.15 | 1.06–1.25 | <0.001 | 1.13 | 1.01–1.26 | 0.033 |
| Acute rejection episodes | 1.10 | 0.93–1.30 | 0.283 | 1.24 | 0.97–1.58 | 0.088 |
| Immuno-induction therapy | 1.08 | 0.99–1.16 | 0.052 | 0.96 | 0.86–1.07 | 0.472 |
| Steroids used at discharge | 1.88 | 1.70–2.09 | <0.001 | 1.81 | 1.55–2.12 | <0.001 |
| TAC used at discharge | 1.52 | 1.26–1.82 | <0.001 | 1.47 | 1.21–1.77 | <0.001 |
| Donor age (≤60 years) | 0.96 | 0.86–1.08 | 0.507 | 0.87 | 0.73–1.04 | 0.119 |
| LDLT | 0.70 | 0.58–0.84 | <0.001 | 0.80 | 0.65–0.99 | 0.035 |
| Male donor | 0.95 | 0.88–1.02 | 0.140 | 0.89 | 0.80–0.99 | 0.039 |
| Donor BMI (≤25 kg/m) | 1.03 | 0.95–1.11 | 0.539 | 1.06 | 0.95–1.19 | 0.273 |
| CIT | 1.03 | 1.01–1.04 | <0.001 | 1.00 | 0.98–1.02 | 0.858 |
| WIT | 1.01 | 1.01–1.02 | <0.001 | 1.01 | 1.01–1.02 | <0.001 |
| Donor with diabetes | 1.16 | 1.04–1.30 | 0.007 | 1.22 | 1.05–1.42 | 0.012 |
| OR – odds ratio; CI – confidence interval; BMI – body mass index; MELD – model for end-stage liver disease; HLA – human leukocyte antigen; CMV – cytomegalovirus; TAC – tacrolimus; LDLT – living donor liver transplantation; CIT – cold ischemia time; WIT – warm ischemia time. | ||||||






